Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background Multiple sclerosis is an inflammatory disease of the central nervous system that destroys myelin, oligodendrocytes, and axons. Since most of the lesions of multiple sclerosis are not remyelinated, enhancement of remyelination is a possible therapeutic strategy that could perhaps be achieved with the transplantation of oligodendrocyte-producing cells into the lesions. We investigated the frequency distribution and configuration of oligodendrocytes in chronic lesions of multiple sclerosis to determine whether these factors limit remyelination. Methods Forty-eight chronic lesions obtained at autopsy from 10 patients with multiple sclerosis were examined immunocytochemically for oligodendrocytes and oligodendrocyte progenitor cells. Using confocal microscopy, we examined the three-dimensional relations between axons and the processes of premyelinating oligodendrocytes. Results Thirty-four of the 48 chronic lesions of multiple sclerosis contained oligodendrocytes with multiple extended processes that associated with demyelinated axons but failed to myelinate them. These axons were dystrophic and contained multiple swellings. In some regions, the densities of premyelinating oligodendrocytes (25 per square millimeter of tissue) were similar to those in the developing rodent brain (23 per square millimeter). In the patients with disease of long duration (more than 20 years), there were fewer lesions with premyelinating oligodendrocytes (P Conclusions Premyelinating oligode…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The efficacy of remyelination has been shown to depend on multiple factors such as, age, disease duration and lesion location.”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [12]
In the citing paper
“The long‐term consequence of demyelination in the CNS is axonal damage and neurodegeneration (Chang et al. 2002) in both white and gray matter lesions, leading to progressive disease.”
From Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination (2026) · cites this paper as Chang et al. 2002
In the citing paper
“In MS lesions, OPCs are recruited but fail to differentiate into myelinating OLs, suggesting that remyelination is blocked at the differentiation and remyelination stage rather than during OPC recruitment (Chang et al., 2002; Kuhlmann et al., 2008; Wolswijk, 1998).”
From miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS (2017) · cites this paper as Chang et al., 2002
In the citing paper
“In MS lesions, OPCs are recruited but fail to differentiate into myelinating OLs, suggesting that remyelination is blocked at the differentiation and remyelination stage rather than during OPC recruitment (Chang et al., 2002; Kuhlmann et al., 2008; Wolswijk, 1998).”
From miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS (2017) · cites this paper as Chang et al., 2002
In the citing paper
“Furthermore, oligodendrocyte progenitor cells (OPCs) are a population of adult stem cells responsible for mediating CNS myelin repair in demyelinating conditions such as MS [113,114].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [114]
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationNoseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Raff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Cell death and control of cell survival in the oligodendrocyte lineage
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
The oligodendrocyte and its many cellular processes
PFEIFFER, S., WARRINGTON, A., & BANSAL, R. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90213-k · Cited by 737
NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions
Chang, A., Nishiyama, A., Peterson, J., Prineas, J., & Trapp, B. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06404.2000 · Cited by 712
Self-citation
Research works printed but not linked: 2
- 10.1056/nejm199801293380610 · doi:10.1056/nejm199801293380610 · Paper page
- Prineas JW, 1989, Lab Invest, 61, 489
Cited by
Items 901–1,000 of 1,000
Past, Present and Future of Cell-Based Therapy in Progressive Multiple Sclerosis
Volpe, G., Bernstock, J. D., Peruzzotti‐Jametti, L., & Pluchino, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_6
Remyelination in Multiple Sclerosis
Bir, S. C., Chernyshev, O. Y., & Minagar, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811709-5.00008-9
Elucidating the functions of fibroblast growth factor 9 in multiple sclerosis
McElroy, D. (2018) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Remyélinisation du système nerveux central et sclérose en plaques
Dubessy, A., & Stankoff, B. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-71420-7.00007-0
Klein, O. A. (2019) · Nottingham ePrints (University of Nottingham)
Demyelinating conditions regulated by ROS pathways outside and inside the brain
Carlström, K. E. (2020) · Figshare · Cited by 1
Imaging and therapy in multiple sclerosis
Brown, J. W. L. (2020) · Apollo (University of Cambridge) · doi:10.17863/cam.52109
“At post-mortem, OPCs are found within the majority of demyelinated lesions (Wolswijk, 1998; Chang et al., 2002) suggesting that – in a large proportion of patients - the limiting step in endogenous remyelination is OPC differentiation (Franklin et al., 2012).”
BackgroundCharacterising the role of AMIGO3 in oligodendrocytes and demyelinating diseases
Foale, S. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
LRP1 is a negative regulator of oligodendrogenesis in the adult mouse central nervous system
Auderset, L. (2020) · UTAS Research Repository · doi:10.25959/100.00034806
Ferreira, S. (2020) · UTAS Research Repository · doi:10.25959/100.00034892
The impact of translational research on the development of therapeutic agents for multiple sclerosis
COHAN, S. L., Lucassen, E. B., Smoot, K. E., Kresa-Reahl, K., Romba, M. C., & Linch, S. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00010-0
Cholesterol metabolism in mouse models of Multiple Sclerosis
Berghoff, S. A. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8239
Laine, M. A. (2021) · Helda - University of Helsinki Institutional Repository
Investigation of myelin maintenance and turnover by inducible MBP knock-out in adult mice
Meschkat, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7679
Fletcher, J. L., Wood, R. J., Prawdiuk, A. R., O’Rafferty, R., Ehrlich, O., Gonsalvez, D. G., & Murray, S. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.19.440405
“More importantly, these are capabilities that are absolutely essential for 333 a candidate remyelinating therapy for MS, in which the primary aim is to overcome arrested OPC 334 differentiation (6,29).”
BackgroundIn vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Mężydło, A. (2020) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.26265
Strategies to Promote Neuroprotection and Repair in Multiple Sclerosis
Ben‐Hur, T. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6068-0.00021-8
White Matter Damage in Multiple Sclerosis
Sánchez‐Gómez, M. V., Pérez‐Cerdá, F., & Matute, C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9123-1_17
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-22085-2.00028-8
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
Future Therapies for Progressive Multiple Sclerosis
Scolding, N. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_11
Neuroaxonale Schädigung in experimentellen Modellen der multiplen Sklerose
Escher, A. (2008) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1328 · Cited by 1
Epigenetische Kontrolle der Remyelinisierung bei Multipler Sklerose
Herget, A. T. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1550
Pathologie und Pathophysiologie
Stadelmann, C., & Brück, W. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-22084-5.00004-4
Martinꝉ, R. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1160036.620302
Guo, X. (2014) · Springer eBooks · doi:10.1007/978-4-431-54965-9_21
Popko, B., & Elbaz, B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732782888.793552935
Charakterisierung der Oligodendroglia in akuten und chronischen Entmarkungsläsionen der Maus
Seitz, N. K. T. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9431
Immunoblot Investigation of Aggrecan Protein in Post-mortem Brain Tissue
Esadawi, A., Woodroof, N., & ELzian, E. M. (2022) · Sirte Journal of Medical Sciences · doi:10.37375/sjms.v1i1.256
Gallego, J., Nevin, M., & Eisenstat, D. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-20792-1_7 · Cited by 1
Focal adhesion kinase, a major regulator of oligodendrocyte morphological maturation and myelination
Lafrenaye, A. D. (2010) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/9rxs-er88
“Although there are oligodendrocyte progenitor cells (OPCs) found within areas of myelin damage there is limited, if any, remyelination (Nait-Oumesmar et al. 1999, Chang et al. 2002).”
BackgroundPDE4 gene inhibition: a novel approach to treat demyelinating disorders
Schepers, M. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230522ms
Relieving the epigenetic blockade in progressive ms: Making remyelination accessible again
Tiane, A. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230606at
Remyelination And Ageing: Ethical Considerations Of Using Surgically Joined Animals In Research
Horn, C. M., Pop, N., & Anderson, M. (2023) · Journal of Undergraduate Neuroscience Education · doi:10.59390/sbpm5289
Vitamin D mechanisms of protection in multiple sclerosis
Hayes, C. E., Astier, A., & Lincoln, M. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00051-3
Pouzol, L. (2022) · theses.fr (ABES) · doi:10.70675/0fb2f93fz85eaz4fa1z8156ze3e7a730899b · Cited by 1
Mechanism of microglia-neuron interaction at the node of Ranvier
Ronzano, R. (2022) · theses.fr (ABES) · doi:10.70675/b851a674z1110z4d43z80e4zee786fda84c7
Analyse fonctionnelle de biomarqueurs de la sclérose en plaques sur les mécanismes de myélinisation
de Terdonck, L. D. T. (2021) · theses.fr (ABES) · doi:10.70675/6c4ac544z94c2z4b54z9a0bz9095aee2af05
Barker, L. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-55297-7_1 · Cited by 1
Kira, J., & Isobe, N. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_15-1
Egimendia, A., de la Pisa, I. L., Padró, D., Colás, L., Plaza‐García, S., Otaegui, D., & Ramos‐Cabrer, P. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70
Tet3 Mediates O-GlcNAcylation-Induced RemyelinationPreprint
Li, Y., Li, P., Song, Y., & Zhang, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.24.634702
Glial cell interactions in neonatal hypoxic-ischemic injury
Ramljak, M., Andrade, M. F., Lacoste, B., Aguilar‐Valles, A., & Salmaso, N. (2025) · Glial health research. · doi:10.1016/j.ghres.2025.100006 · Cited by 1
Novel Animal Models for Multiple Sclerosis: R-Ras GTPases in Myelin Pathophysiology
Esteban-Ortega, G. M., Garcia‐Martin, G., & Cubelos, B. (2025) · Biomolecules · doi:10.3390/biom15091309
“Likewise, in multiple sclerosis lesions, the presence of premyelinating oligodendrocytes is suggestive that the initial steps of differentiation may not be impaired but instead the ability to find suitable axons to remyelinate or survival may be impacted [43,44].”
Oligodendrocyte progenitor cell responses to inflammatory demyelination with agingPreprint
Fresenko, E. E., Bahri, C. N., Ahmed, N. F., Packer, D., Tabor, B. J., Sun, W., Wedemeyer, M. A., & Harrington, C. A. (2025) · Research Square · doi:10.21203/rs.3.rs-7614774/v1
“OPCs and maturing oligodendrocytes have been identi�ed in MS lesions from patients of all ages (9, 10) suggesting that OPCs may retain the capacity to differentiate and remyelinate after a demyelinating attack despite an inhibitory in�ammatory environment (8, 11).”
Fresenko, E. E., Bahri, C. N., Burson, B. J., Ahmed, N. F., Packer, D., Tabor, B. J., Beirowski, B., Sun, W., Wedemeyer, M. A., & Harrington, C. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.22.677854
“OPCs and maturing oligodendrocytes have been identified in MS lesions from patients of all ages (9,10) suggesting that OPCs may retain the capacity to differentiate and remyelinate after a demyelinating attack despite an inhibitory inflammatory environment (8,11).”
Physiopathologie de la sclérose en plaques
Dubessy, A., & Stankoff, B. (2025) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(25)46803-1
Inflammatory Demyelination and Autophagic Dysfunction in Multiple Sclerosis
Halagali, P., Nair, S. P., Manjula, S. N., Sharma, H., & Tippavajhala, V. K. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_12
Chemokines and Autoimmune Demyelination
Fux, M., Millward, J. M., & Owens, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_9
Oligodendrocytes as active modulators of neuroinflammation
Janssen, K., & Beyer, C. (2014) · RWTH Publications (RWTH Aachen)
Magnetic resonance imaging in relapsing-remitting multiple sclerosis
Chard, D. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Axelsson, M. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Additional file 3 of ANGPTL2 binds MAG to efficiently enhance oligodendrocyte differentiation
Chen, L., Yu, Z., Xie, L., He, X., Mu, X., Chen, C., Yang, W., Tong, X., Liu, J., Gao, Z., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22606052
Smith, B. C., Tinkey, R. A., Brock, O. D., Mariam, A., Habean, M. L., Dutta, R., & Williams, J. L. (2024) · Figshare · doi:10.6084/m9.figshare.26626225
Additional file 2 of ANGPTL2 binds MAG to efficiently enhance oligodendrocyte differentiation
Chen, L., Yu, Z., Xie, L., He, X., Mu, X., Chen, C., Yang, W., Tong, X., Liu, J., Gao, Z., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22606049
Scheld, M. (2019) · RWTH Publications (RWTH Aachen) · doi:10.18154/rwth-2019-05099
Ertl, C. (2021) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.28268
Additional file 1 of ANGPTL2 binds MAG to efficiently enhance oligodendrocyte differentiation
Chen, L., Yu, Z., Xie, L., He, X., Mu, X., Chen, C., Yang, W., Tong, X., Liu, J., Gao, Z., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22606046
Metabolic treatments in murine models of multiple sclerosis
Alaeiilkhchi, N. (2023) · cIRcle (University of British Columbia) · doi:10.14288/1.0438320 · Cited by 1
Protective effect of aerobic exercise on myelin lesions in an AD model and its mechanism
Qiu, D. (2021) · Cross Connect (Southern Cross University) · doi:10.25918/thesis.420
Lohrberg, M., Winkler, A., Franz, J., van der Meer, F., Ruhwedel, T., Sirmpilatze, N., Dadarwal, R., Löber-Handwerker, R., Esser, D. S., Wiegand, K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13488672
Teipel, F. (2020) · URN:NBN Resolver for Germany & Switzerland (German National Library) · Cited by 1
Klein, A.-K. (2020) · mediaTUM (Technical University of Munich)
Helicobacter pylori: cellular immunity and protection from Multiple Sclerosis
Jenkins, H. H. (2022) · Nottingham ePrints (University of Nottingham)
Bravo-Jimenez, M. A. (2023) · Mspace (University of Manitoba) · Cited by 1
Fisiopatologia della sclerosi multipla
Dubessy, A., & Stankoff, B. (2026) · EMC - Neurologia · doi:10.1016/s1634-7072(25)51364-8
Zi, H., Goldbrunner, A., Askari, S., Eichenseer, K., Misgeld, T., & Snaidero, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.15.705957
The Gut–Myelin Axis: Microbial Metabolites in Oligodendrocyte Biology and RemyelinationPreprint
Alegre, E. O. T., & Jiménez, D. E. M. (2026) · Preprints.org · doi:10.20944/preprints202602.1855.v1 · Cited by 1
Nox4欠失はミクログリアおよびマクロファージの貪食能を向上させクプリゾン誘発性脱髄モデルマウスにおける再髄鞘化を促進する
山中, 圭. (2024) · Institutional Repositories DataBase (IRDB)
Rôles des androgènes et de leur récepteur AR dans le dimorphisme et la réparation de la myéline
Abi‐Ghanem, C. (2016) · theses.fr (ABES) · doi:10.70675/c7a8d4f5z2330z4437z89a4z7ddf73a92b07
Hmidan, H. (2016) · theses.fr (ABES) · doi:10.70675/a55bc69fze6c8z4324za45czc4b1253f732e
Macrophage activation profiles of multiple sclerosis patients
Fransson, J. (2019) · theses.fr (ABES) · doi:10.70675/361929ebz66c2z48dbz83a1z8955d8b54716 · Cited by 1
Characterization of Tns3 molecular mechanisms in oligodendrogenesis
Merour, E. (2021) · theses.fr (ABES) · doi:10.70675/ff1209dazde97z429ez9b2az5593a14d4080
Lazzarotto, A. (2023) · theses.fr (ABES) · doi:10.70675/245e2c82zb2bdz4b9dzbd16zc18dbdc9732b
Caractérisation des modifications cérébrales post-névrite optique en magnétoencéphalographie
Beigneux, Y. (2024) · theses.fr (ABES) · doi:10.70675/947313acz9323z4145zbb4ez49197aa68e69
Nonlinear optical microscopy of nervous tissue : lipid and metabolism imaging
Asadipour, B. (2023) · theses.fr (ABES) · doi:10.70675/a6df7cc5z7b3cz4971zb3edzfa969cc63866
Identification and characterization of Sonic Hedgehog signal for brain maintenance and repair
Russo, M. (2023) · theses.fr (ABES) · doi:10.70675/76dce8acz0153z49ecza2f8zf494f96ab226
Microenvironmental Regulation of Central Nervous System Myelination and Remyelination
Wang, Y., Tan, L., Lao, L., Huang, X., Zhang, S., & Sun, H. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin43257 · Cited by 1
Myelin Repair as a Neuroprotective Strategy for Multiple Sclerosis: From Bench to Bedside
Battah, T., Mastorodemos, V., Struecker, E., Mitsikostas, D. D., & Papadopoulos, D. (2026) · Medicina · doi:10.3390/medicina62061183
“This suggests that the biological processes that drive aging may be a limiting factor for remyelination in advanced stages of multiple sclerosis [83,84].”
Zhang, Z. D., Yan, M., Huang, W., Chen, Y., Lv, T., & Chen, W. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71000
Astrocytes in Multiple Sclerosis: Getting to the Core
Tinkey, R. A., Smith, B. C., & Williams, J. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146520
Sapra, A., Kumar, N., Niepokny, T. D., Courtney, H., Tripathi, A. K., & Dutta, R. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70488
Chakrabarti, S., Jana, M., Gorai, S., & Pahan, K. (2026) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2026-0021
Immune Modulation and Repair Following Neural Stem Cell Transplantation
Ben‐Hur, T., Pluchino, S., & Martino, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_7
The importance of the Hedgehog signaling pathway at the level of the blood-brain barrier
Dodelet-Devillers, A. (2009) · doi:10.71781/29601
ROLES OF FAS IN NEURAL PROGENITOR CELL DIFFERENTIATION, SURVIVAL, AND IMMUNE-CELL INTERACTIONS
Knight, J. C. (2011) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Metadata
- Authors
- Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D.
- Affiliations
- Cleveland Clinic (US)
- VA West Los Angeles Medical Center (US)
- Cleveland Clinic Research (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-01-17
- Volume
- 346
- Issue
- 3
- Pages
- 165-173
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2058358434
- Cited by
- 991
- References
- 39
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 42 · 2023: 38 · 2022: 32 · 2021: 34 · 2020: 36 · 2019: 57 · 2018: 43 · 2017: 52 · 2016: 44 · 2015: 55 · 2014: 44 · 2013: 50 · 2012: 40
- FWCI
- 26.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01 NS35058, P01NS038667, R01NS035058, P01-NS-38667)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- multiple sclerosis, remyelination, chronic lesions, demyelinated axons, oligodendrocyte precursor cells, disease duration
- MeSH terms
- Chondroitin Sulfate Proteoglycan 4, Adult, Aged, Antigens, Axons, Brain, Brain Chemistry, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Nerve Fibers, Myelinated, Oligodendroglia, Proteoglycans, Stem Cells, Microscopy, Confocal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.